Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone

被引:2
|
作者
Arhin, Martin [1 ]
Mobley, Julian [1 ]
Hamad, Hamad [2 ]
Remick, Paul [2 ]
机构
[1] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA
[2] Geisinger Commonwealth Sch Med, Family Med, Scranton, PA USA
关键词
opioid use; methadone clinic; buprenorphine and naloxone; opioid taper; kratom addiction;
D O I
10.7759/cureus.41146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kratom is an unregulated herbal supplement that is growing in popularity in the United States. Its primary active ingredients, mitragynine, and 7-hydroxymitragynine, are partial agonists that act on mu-and delta-opioid receptors in the central nervous system, producing analgesia and a sense of euphoria. Kratom use can lead to addiction and adverse side effects, such as seizures, hallucinations, and coma. This case report presents a male in his 40s with a history of kratom use, who presented to the clinic seeking help for his addiction. The patient had been using kratom for several years to self-medicate for his anxiety and depression and gradually developed a kratom addiction. The patient was successfully treated with buprenorphine/naloxone, which helped alleviate his withdrawal symptoms and allowed him to abstain from kratom. This case underscores the growing issue of kratom addiction in the United States and the critical need for physician awareness in treating withdrawal.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] eComparison of oral buprenorphine/naloxone, depot buprenorphine and methadone for patients released from custodial settings with opioid use disorder
    Shi, Avelyn
    Naz, Rokshar
    Hanby, Matthew F.
    McKenzie, Cameron R. L.
    Moe, Syed
    Dunlop, Adrian J.
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S164 - S164
  • [42] Buprenorphine-Naloxone Therapy in Pain Management
    Chen, Kelly Yan
    Chen, Lucy
    Mao, Jianren
    ANESTHESIOLOGY, 2014, 120 (05) : 1262 - 1274
  • [43] Illicit use and diversion of buprenorphine/naloxone among patients in buprenorphine/naloxone maintenance treatment in Istanbul, Turkey
    Evren, Cuneyt
    Bozkurt, Muge
    Cetin, Turan
    Karabulut, Vahap
    Evren, Bilge
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2014, 16 (01) : 25 - 34
  • [44] Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder
    Shcherbakova, Natalia
    Tereso, Gary
    Spain, Jacqueline
    Roose, Robert J.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (05) : 405 - 414
  • [45] Comparative Analysis of Instrumental Variables on the Assignment of Buprenorphine/Naloxone or Methadone for the Treatment of Opioid Use Disorder
    Homayra, Fahmida
    Enns, Benjamin
    Min, Jeong Eun
    Kurz, Megan
    Bach, Paxton
    Bruneau, Julie
    Greenland, Sander
    Gustafson, Paul
    Karim, Mohammad Ehsanul
    Korthuis, P. Todd
    Loughin, Thomas
    Maclure, Malcolm
    Mccandless, Lawrence
    Platt, Robert William
    Schnepel, Kevin
    Shigeoka, Hitoshi
    Siebert, Uwe
    Socias, Eugenia
    Wood, Evan
    Nosyk, Bohdan
    EPIDEMIOLOGY, 2024, 35 (02) : 218 - 231
  • [46] Independent community pharmacists' attitudes and intentions toward dispensing buprenorphine/naloxone for opioid use disorder
    Zalmai, Rana
    Hill, Lucas G.
    Loera, Lindsey J.
    Mosgrove, Quinn
    Brown, Carolyn
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (05) : 1558 - 1565.e4
  • [47] Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder
    Becker, William C.
    Ganoczy, Dara
    Fiellin, David A.
    Bohnert, Amy S. B.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 48 (01) : 128 - 131
  • [48] Enhancing staff confidence to initiate buprenorphine-naloxone for opioid use disorder in an Ontario ED
    Ovini Thomas
    Megan Park
    Barb McGovern
    Sarah McClennan
    Canadian Journal of Emergency Medicine, 2025, 27 (2) : 153 - 154
  • [49] Primary care management of opioid use disorders Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava, Anita
    Kahan, Meldon
    Nader, Maya
    CANADIAN FAMILY PHYSICIAN, 2017, 63 (03) : 200 - 205
  • [50] Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone
    Jones, Alexis C.
    Tillman III, Frank
    Kahlon, Christie
    Seys, Randy
    Pepin, Marc
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2024, 64 (03)